Concepedia

Zhen Xu

ZX

Statistics

Publications

28

Citations

2K

H-Index

17

Active since

2012

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

The University of Melbourne

Peter MacCallum Cancer Centre

Monash University

The Royal Melbourne Hospital

Zhen Xu is an author at Walter and Eliza Hall Institute of Medical Research specializing in molecular biology, molecular oncology, and life sciences.

ORCID

Publications per year

2012–2024

28

Publications

28

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

Courtney D. DiNardo, Ing Soo Tiong, Anna Quaglieri et al. · Blood · 2020 · 649 citations · Full text

, , +9

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia

Piers Blombery, Mary Ann Anderson, Jianan Gong et al. · Cancer Discovery · 2018 · 426 citations · Full text

, , +10

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias

Rachel Thijssen, Sarah T. Diepstraten, Donia M. Moujalled et al. · Blood · 2021 · 135 citations · Full text

, , +12

NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression

Junyi Ju, Aiping Chen, Yexuan Deng et al. · Nature Communications · 2017 · 113 citations · Full text

, , +16

Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells

Zhen Xu, Cuiui Liu, Qian Zhao et al. · Pharmacological Research · 2020 · 74 citations

, , +16

1–5 of 28